BIOMAT Database Logo BIOMAT Database Logo

Evaluation and eligibility of HLA-identical sibling donors for stem cell/bone marrow donation. 1998

A E Morrison, and R H Green, and D M Watson, and I M Franklin
Clinical Apheresis Unit, Royal Infirmary, Glasgow, UK.

Overall, the number of allogeneic transplants performed world-wide has not increased dramatically over the past 5 years. However, the proportion of allogeneic transplants undertaken using peripheral blood progenitor cells (PBPCs) has risen significantly. Currently, as part of an ethically approved trial, potential donors are seen, assessed and consented by physicians not caring directly for the recipients. Thirty-five potential sibling donors were seen and assessed for their willingness and fitness to donate for 28 patients. One donor opted to give bone marrow and the rest selected PBPC donation. Seven of these donors were found to have concurrent medical conditions. Due to poor venous access, one donor was advised to donate bone marrow and two others donated bone marrow due to an underlying condition. Four others were deemed unfit for donation. Donation of stem cells from bone marrow or peripheral blood is not a risk-free procedure; careful preassessment and counselling is mandatory especially when the age of prospective patients and therefore donors is increasing.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009679 Nuclear Family A family composed of spouses and their children. Daughters,Sons,Daughter,Families, Nuclear,Family, Nuclear,Nuclear Families,Son
D004608 Eligibility Determination Criteria to determine eligibility of patients for medical care programs and services. Eligibility Certification,Certification, Eligibility,Certifications, Eligibility,Determination, Eligibility,Determinations, Eligibility,Eligibility Certifications,Eligibility Determinations
D005260 Female Females
D005500 Follow-Up Studies Studies in which individuals or populations are followed to assess the outcome of exposures, procedures, or effects of a characteristic, e.g., occurrence of disease. Followup Studies,Follow Up Studies,Follow-Up Study,Followup Study,Studies, Follow-Up,Studies, Followup,Study, Follow-Up,Study, Followup
D006650 Histocompatibility Testing Identification of the major histocompatibility antigens of transplant DONORS and potential recipients, usually by serological tests. Donor and recipient pairs should be of identical ABO blood group, and in addition should be matched as closely as possible for HISTOCOMPATIBILITY ANTIGENS in order to minimize the likelihood of allograft rejection. (King, Dictionary of Genetics, 4th ed) Crossmatching, Tissue,HLA Typing,Tissue Typing,Crossmatchings, Tissue,HLA Typings,Histocompatibility Testings,Testing, Histocompatibility,Testings, Histocompatibility,Tissue Crossmatching,Tissue Crossmatchings,Tissue Typings,Typing, HLA,Typing, Tissue,Typings, HLA,Typings, Tissue
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D016026 Bone Marrow Transplantation The transference of BONE MARROW from one human or animal to another for a variety of purposes including HEMATOPOIETIC STEM CELL TRANSPLANTATION or MESENCHYMAL STEM CELL TRANSPLANTATION. Bone Marrow Cell Transplantation,Grafting, Bone Marrow,Transplantation, Bone Marrow,Transplantation, Bone Marrow Cell,Bone Marrow Grafting

Related Publications

A E Morrison, and R H Green, and D M Watson, and I M Franklin
Combined umbilical cord blood and bone marrow from HLA-identical sibling donors for hematopoietic stem cell transplantation in children with hemoglobinopathies.
September 2014, Pediatric blood & cancer,
A E Morrison, and R H Green, and D M Watson, and I M Franklin
Selection of marrow donors for patients lacking an HLA-identical sibling.
January 1990, Cancer treatment and research,
A E Morrison, and R H Green, and D M Watson, and I M Franklin
Bone marrow donation from the perspective of sibling donors.
January 2010, Revista latino-americana de enfermagem,
A E Morrison, and R H Green, and D M Watson, and I M Franklin
Bone marrow transplantation from alternative donors for thalassemia: HLA-phenotypically identical relative and HLA-nonidentical sibling or parent transplants.
April 2000, Bone marrow transplantation,
A E Morrison, and R H Green, and D M Watson, and I M Franklin
Bone marrow as stem cell source for allogeneic HLA-identical sibling transplantation following reduced-intensity preparative regimen.
October 2003, Experimental hematology,
A E Morrison, and R H Green, and D M Watson, and I M Franklin
Allogeneic bone marrow transplantation for chronic myeloid leukemia using HLA identical sibling donors primed with G-CSF.
August 2002, Zhongguo shi yan xue ye xue za zhi,
A E Morrison, and R H Green, and D M Watson, and I M Franklin
Multiple minor histocompatibility antigen disparities between a recipient and four HLA-identical potential sibling donors for bone marrow transplantation.
August 1993, Human immunology,
A E Morrison, and R H Green, and D M Watson, and I M Franklin
[Clinical contrasting study on hematopoietic stem cell transplantation from HLA-identical sibling and partially HLA-mismatched related donors].
August 2008, Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi,
A E Morrison, and R H Green, and D M Watson, and I M Franklin
Individual HLAs influence immunological events in allogeneic stem cell transplantation from HLA-identical sibling donors.
March 2021, Bone marrow transplantation,
A E Morrison, and R H Green, and D M Watson, and I M Franklin
CTLA-4 polymorphisms and clinical outcome after allogeneic stem cell transplantation from HLA-identical sibling donors.
July 2007, Blood,
Copied contents to your clipboard!